2018 Q3 Form 10-Q Financial Statement

#000114420418044664 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q2
Revenue $52.40K $4.800K $0.00
YoY Change
Cost Of Revenue $36.40K $2.528K $0.00
YoY Change
Gross Profit $16.01K $2.272K $0.00
YoY Change
Gross Profit Margin 30.54% 47.33%
Selling, General & Admin $280.0K $310.0K $370.0K
YoY Change 40.0% -16.22% 94.74%
% of Gross Profit 1749.45% 13644.37%
Research & Development $2.884K $4.200K $25.19K
YoY Change -96.71% -83.33% 39.72%
% of Gross Profit 18.02% 184.86%
Depreciation & Amortization $10.00K $0.00 $10.00K
YoY Change -100.0%
% of Gross Profit 62.48% 0.0%
Operating Expenses $290.8K $317.1K $396.0K
YoY Change -1.41% -19.92% 90.29%
Operating Profit -$274.8K -$314.8K -$396.0K
YoY Change -6.84% -20.5% 89.25%
Interest Expense $377.0K $413.0K $63.24K
YoY Change 190.53% 553.06% 5399.13%
% of Operating Profit
Other Income/Expense, Net -$1.296M -$6.118M -$490.4K
YoY Change -633.81% 1147.56% 42540.43%
Pretax Income -$1.571M -$6.432M -$886.4K
YoY Change 2910.66% 625.71% 322.07%
Income Tax
% Of Pretax Income
Net Earnings -$1.571M -$6.432M -$886.4K
YoY Change 2910.66% 625.71% 323.59%
Net Earnings / Revenue -2998.13% -134008.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.593K -$7.728K -$6.255K
COMMON SHARES
Basic Shares Outstanding 717.1M shares 106.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.0K $100.0K $100.0K
YoY Change 750.0% 0.0% 233.33%
Cash & Equivalents $172.8K $100.5K $104.4K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $14.00K $4.800K
Other Receivables $0.00 $0.00
Total Short-Term Assets $186.8K $105.3K $100.0K
YoY Change 780.62% 5.3% 233.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $168.8K $174.1K $199.6K
YoY Change -10.59% -12.79% 117.73%
TOTAL ASSETS
Total Short-Term Assets $186.8K $105.3K $100.0K
Total Long-Term Assets $168.8K $174.1K $199.6K
Total Assets $355.6K $279.4K $299.6K
YoY Change 69.34% -6.75% 146.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $242.8K $272.8K $53.20K
YoY Change 51.78% 412.8% 107.8%
Accrued Expenses $29.64K $40.06K $9.869K
YoY Change 196.4% 305.87% 260.71%
Deferred Revenue
YoY Change
Short-Term Debt $130.0K $130.0K $270.0K
YoY Change -48.0% -51.85% 285.71%
Long-Term Debt Due $210.0K $240.0K
YoY Change 61.54%
Total Short-Term Liabilities $7.710M $10.87M $1.314M
YoY Change 507.05% 727.41% 332.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -85.71%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -85.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.710M $10.87M $1.314M
Total Long-Term Liabilities $0.00 $0.00 $10.00K
Total Liabilities $7.710M $10.87M $1.322M
YoY Change 502.31% 722.23% 254.42%
SHAREHOLDERS EQUITY
Retained Earnings -$19.02M -$17.44M -$1.896M
YoY Change 819.94% 430.29%
Common Stock $11.66M $6.850M $873.7K
YoY Change 683.97% 722.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.354M -$10.59M -$1.020M
YoY Change
Total Liabilities & Shareholders Equity $355.6K $279.4K $299.6K
YoY Change 69.34% -6.75% 146.23%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$1.571M -$6.432M -$886.4K
YoY Change 2910.66% 625.71% 323.59%
Depreciation, Depletion And Amortization $10.00K $0.00 $10.00K
YoY Change -100.0%
Cash From Operating Activities -$350.0K -$250.0K -$270.0K
YoY Change 25.0% -7.41% 170.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $100.0K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$100.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 420.0K 250.0K 380.0K
YoY Change 366.67% -34.21% 245.45%
NET CHANGE
Cash From Operating Activities -350.0K -250.0K -270.0K
Cash From Investing Activities 0.000 -100.0K
Cash From Financing Activities 420.0K 250.0K 380.0K
Net Change In Cash 70.00K 0.00000000008731 10.00K
YoY Change -177.78% -100.0% 0.0%
FREE CASH FLOW
Cash From Operating Activities -$350.0K -$250.0K -$270.0K
Capital Expenditures $0.00 $100.0K
Free Cash Flow -$250.0K -$370.0K
YoY Change -32.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div> &#8211; The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. &#160;Actual results could differ from those estimates.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Revenues
Revenues
14400 USD
us-gaap Revenues
Revenues
0 USD
CY2018Q2 us-gaap Revenues
Revenues
4800 USD
CY2017Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1877 USD
us-gaap Share Based Compensation
ShareBasedCompensation
142423 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
140957 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
118434 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
554658 USD
us-gaap Cost Of Revenue
CostOfRevenue
4928 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2528 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Gross Profit
GrossProfit
9472 USD
us-gaap Gross Profit
GrossProfit
0 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
2272 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
0 USD
dei Document Type
DocumentType
10-Q
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
673092 USD
CY2018Q2 us-gaap Cash
Cash
100501 USD
CY2017Q4 us-gaap Cash
Cash
13697 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4800 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4801 USD
dei Amendment Flag
AmendmentFlag
false
us-gaap Net Income Loss
NetIncomeLoss
-1129707 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
2512357 USD
CY2018Q2 us-gaap Assets
Assets
279378 USD
CY2017Q4 us-gaap Assets
Assets
203147 USD
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7400 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85020 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4200 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25189 USD
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
CY2018Q2 us-gaap Assets Current
AssetsCurrent
105301 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
18498 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
510546 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
546394 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
307616 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
368016 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10572 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5423 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5286 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2786 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
174077 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
184649 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1309190 USD
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
dei Entity Registrant Name
EntityRegistrantName
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
549495 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
55941 USD
us-gaap Operating Expenses
OperatingExpenses
528518 USD
us-gaap Operating Expenses
OperatingExpenses
636837 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
317102 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
395991 USD
CY2018Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3271870 USD
CY2018Q2 us-gaap Management Fee Payable
ManagementFeePayable
254050 USD
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-4822943 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
10930166 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q4 us-gaap Management Fee Payable
ManagementFeePayable
352750 USD
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
239980 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
502000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-519046 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-636837 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-314830 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-395991 USD
celz Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
12500 USD
celz Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
0 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001187953
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-13392280 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-427125 USD
us-gaap Interest Expense
InterestExpense
604303 USD
us-gaap Interest Expense
InterestExpense
65745 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
412995 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
63240 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
496645 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9928770 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
272831 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
237566 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40055 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23140 USD
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
dei Trading Symbol
TradingSymbol
CELZ
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
496645 USD
CY2018Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
650929 USD
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13392280 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
427125 USD
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6355508 USD
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
427125 USD
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
717148155 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
251748 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35265 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13181 USD
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
677730755 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115399226 shares
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13499938 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-492870 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6117574 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-490365 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0263 pure
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14018984 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1129707 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6432404 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-886356 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
52637 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5754 USD
CY2018Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
125000 USD
CY2017Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
125000 USD
CY2018Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
125000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
51300 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
13000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14018984 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6432404 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-886356 USD
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
93000000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-409702 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-493222 USD
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
10800 USD
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
10800 USD
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9928770 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1309190 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
407236924 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
105667617 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
623924281 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
106226387 shares
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
100000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10871486 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2435194 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100000 USD
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
915 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
90000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
189800 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2018Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 USD
CY2017Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3211 USD
CY2018Q2 us-gaap Liabilities
Liabilities
10871486 USD
CY2017Q4 us-gaap Liabilities
Liabilities
2439320 USD
celz Prepayment Premium Paid On Convertible Debt
PrepaymentPremiumPaidOnConvertibleDebt
57004 USD
celz Prepayment Premium Paid On Convertible Debt
PrepaymentPremiumPaidOnConvertibleDebt
0 USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 celz Working Capital Deficit
WorkingCapitalDeficit
10766185 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
743310 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
285750 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17444664 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
92775038 shares
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
677133 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
114800 USD
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6172423 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1074707 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
86804 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-117472 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13697 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
221868 USD
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
From March 2017 through May 2018, the Company issued 78,526,087 warrants to multiple parties associated with the issuance of convertible notes. The issued warrants expire 5 years from the date of issuance and have anti-dilution and re-pricing features.
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
677130755 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114799226 shares
celz Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
0 USD
celz Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
100000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3425680 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100501 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104396 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279378 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
203147 USD
celz Reimbursement Of Management Fees
ReimbursementOfManagementFees
35000 USD
us-gaap Interest Paid Net
InterestPaidNet
6670 USD
us-gaap Interest Paid Net
InterestPaidNet
4050 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
celz Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
0 USD
celz Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
5546 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
5511172 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2017Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
50000 USD
CY2017Q4 celz Management Reimbursement Agreement Description
ManagementReimbursementAgreementDescription
At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days&#8217; prior written notice.
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
54200 USD
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4000 USD
CY2018Q1 us-gaap Legal Fees
LegalFees
2000 USD
celz Warrant Term
WarrantTerm
P5Y
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
23426087 shares
celz Class Of Warrant Issued
ClassOfWarrantIssued
66176923 shares
celz Warrant Exercises
WarrantExercises
-156560322 shares
celz Warrant Antidilution And Modification
WarrantAntidilutionAndModification
159727241 shares
celz Warrant Forfeitures Or Cancellations
WarrantForfeituresOrCancellations
-15200000 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
77569929 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0038
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10592108 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2236173 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
496506 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
475750 USD
us-gaap Stock Issued1
StockIssued1
150000 USD
us-gaap Stock Issued1
StockIssued1
0 USD

Files In Submission

Name View Source Status
0001144204-18-044664-index-headers.html Edgar Link pending
0001144204-18-044664-index.html Edgar Link pending
0001144204-18-044664.txt Edgar Link pending
0001144204-18-044664-xbrl.zip Edgar Link pending
celz-20180630.xml Edgar Link completed
celz-20180630.xsd Edgar Link pending
celz-20180630_cal.xml Edgar Link unprocessable
celz-20180630_def.xml Edgar Link unprocessable
celz-20180630_lab.xml Edgar Link unprocessable
celz-20180630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv500594_10q.htm Edgar Link pending
tv500594_ex31-1.htm Edgar Link pending
tv500594_ex31-2.htm Edgar Link pending
tv500594_ex32-1.htm Edgar Link pending
tv500594_ex32-2.htm Edgar Link pending